Naproxen Sodium 220mg
NDC 69168-395, Naproxen Sodium 220mg, tablet, coated, from Allegiant Health.
- Product NDC
- 69168-395
- Status
- Listed
- Labeler
- Allegiant Health
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA090545
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69168-395 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69168-395-07 | 69168039507 | 10 TABLET, COATED in 1 BOTTLE (69168-395-07) |
| 69168-395-17 | 69168039517 | 300 TABLET, COATED in 1 BOTTLE (69168-395-17) |
| 69168-395-50 | 69168039550 | 50 TABLET, COATED in 1 BOTTLE (69168-395-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 69168-395 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69168-395 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69168-395. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.